NeoGenomics NEO Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $146.14M-8.4% | $159.62M-2.7% | $164.12M+6.1% | $154.72M-55.3% | $346.19M-5.7% | ||
| $167.42M+5.1% | $159.24M+2.5% | $155.3M+1.4% | $153.13M+1.3% | $151.21M+0.4% | ||
| $29.84M+4.4% | $28.57M+0.4% | $28.46M-16.7% | $34.17M+14.8% | $29.77M+11.3% | ||
| $373.68M-0.7% | $376.29M-1.6% | $382.47M-2.6% | $392.55M-31.6% | $573.93M-3.7% | ||
| $83.66M-1.4% | $84.83M-0.7% | $85.47M0.0% | $85.46M-4.6% | $89.6M-4.8% | ||
| $524M-0.1% | $524.34M0.0% | $524.34M0.0% | $524.14M+0.3% | $522.77M0.0% | ||
| $265.45M-7.4% | $286.53M+2.1% | $280.72M-2.6% | $288.35M-9.3% | $317.87M-6.4% | ||
| $972.85M-1.1% | $983.54M-0.9% | $992.32M-0.9% | $1B-2.5% | $1.03B-1.4% | ||
| $1.35B-1.0% | $1.36B-1.1% | $1.37B-1.4% | $1.39B-13.0% | $1.6B-2.2% | ||
| $25.9M+12.2% | $23.09M+2.1% | $22.61M-17.8% | $27.49M+69.6% | $16.21M-25.0% | ||
| $561K-34.1% | $851K-46.0% | $1.58M+45.4% | $1.08M-6.8% | $1.16M+184% | ||
| $84.59M-4.2% | $88.3M-9.8% | $97.87M-2.3% | $100.12M-64.2% | $279.7M-7.2% | ||
| $433.18M-0.4% | $434.97M-0.8% | $438.62M-0.3% | $439.79M+1.5% | $433.47M-0.2% | ||
| $517.77M-1.1% | $523.27M-2.5% | $536.49M-0.6% | $539.91M-24.3% | $713.16M-3.1% | ||
| $129K0.0% | $129K+0.8% | $128K0.0% | $128K0.0% | $128K0.0% | ||
| -$450.91M-3.9% | -$433.81M-2.3% | -$423.93M-6.8% | -$396.8M-12.8% | -$351.7M-8.0% | ||
| $828.76M-0.9% | $836.56M-0.2% | $838.29M-1.8% | $854.04M-3.9% | $888.27M-1.6% | ||
| $1.35B-1.0% | $1.36B-1.1% | $1.37B-1.4% | $1.39B-13.0% | $1.6B-2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are NeoGenomics's total assets?
- NeoGenomics (NEO) holds $1.3B in total assets, down 15.9% year over year.
- How much debt does NeoGenomics have?
- NeoGenomics carries $66.3M in total debt against $828.8M of shareholders' equity, a debt-to-equity ratio of 0.08.
- How much cash does NeoGenomics have?
- NeoGenomics holds $146.1M in cash and equivalents.
- Can NeoGenomics cover its short-term obligations?
- Its current ratio is 4.42 — current assets exceed current liabilities.
- Where does NeoGenomics's balance sheet data come from?
- Every line is extracted from NeoGenomics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
